Marker Therapeutics Inc (MRKR)

[Bio7mm]

Initial dilution from preferred share conversion will not be that bad. The reverse spilt will bring us down to 1.5 million shares. The insiders preferred shares of approx 278k will become a little more than 1.3 million shares bringing us to 2.8 million+ shares. Yes 50% dilution before a capital raise but you have to look at market cap. If Tapimmune, after a capital raise has 5 million shares outstanding at 2$ per share, we are still only a $10 million market cap company! What is Innovio's market cap? If we then grow to even a tiny $100 million market cap, you have gained 1000%! Imagine if we grow to $10 billion! That is very doable over the next 8-10 years! Look at the size of the markets we are addressing! Tens of billions of dollars! Most people could not fathom how large Microsoft or Cisco would become when they started out. Most people don't have the ability to see the future and what could happen!